AzTrials
AzTrials

Offense, SexEV-AICSNCT05013996

Impact of a Structured Clinical Assessment MIDSA, Its Feedback and Support for Change on Commitment to Care of Perpetrators of Sexual Offenses

A study testing MIDSA and Usual methods of evaluation in people with Offense, Sex, run by University Hospital, Tours at 5 sites in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Evaluate the effectiveness of an intervention including the clinical assessment carried out with the (Multidimensional Inventory of Development, Sex, and Aggression) MIDSA and the review of the results with the professional in charge of the subject on the adherence and commitment to the care of the sexual offenders. Read more about this study

Who is it for?
Ages 18 years and older, men only
Conditions the study is for
Offense, Sex
What is being tested?
MIDSA and Usual methods of evaluation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
5 sitesFrance
Study dates
20 Jan 2022to 14 Jan 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult male patients
  • Express written consent of the participant after receiving the study information
  • Subject making contact or being taken in charge by a psychiatric service (even an addictology service or by liberal practitioners in connection with psychiatry), a CRIAVS or a care unit dedicated to the care of perpetrators of a sexual offense (AICS) ;
  • For a problem of sexual violence such as sexual harassment, assault and rape of adult women (including marital rape), incest, pedophilic or hebephilic acts, sexual sadism, exhibition, voyeurism, frotteurism, use and possession of child pornography or addiction sexual.
  • Affiliated to a social security scheme

Who cannot join

  • Maximum stage (maintenance phase) listed on the URICA scale
  • Poor understanding of the French language;
  • Patient imprisoned, under legal protection, under guardianship or curatorship

Trial locations and contacts

5 sites in 1 country.

5 sites in 1 country

France5 sites
  • CHRU Lille - URSAVS Lille

    Lille, 59000

  • CH LE Vinatier - Service de Psychiatrie Légale

    Lyon, 69000

  • CHU Montpellier Lapeyronie - CRIAVS Languedoc-Roussillon

    Montpellier, 34000

  • CHU Poitiers Henri Laborit - CRIAVS - CMP Espace Vienne - SMPR

    Poitiers, 86000

  • CHRU Tours - UC3P

    Tours, 37044

Other trials in France

About this study

Official title: Impact d'un Bilan Clinique structuré (MIDSA), de sa Restitution et de l'Accompagnement au Changement Sur l'Engagement Dans le Soin (évalué Par l'échelle URICA) d'Auteurs d'Infraction à caractère Sexuel : Essai contrôlé randomisé Multicentrique en Ouvert

Evaluate the effectiveness of an intervention including the clinical assessment carried out with the (Multidimensional Inventory of Development, Sex, and Aggression) MIDSA and the review of the results with the professional in charge of the subject on the adherence and commitment to the care of the sexual offenders.

Read the detailed description

The intervention of MIDSA (Multidimensional Inventory of Development, Sex, and Aggression), a multidimensional investigation tool for issues related to sexuality and violence, could be prove very useful by providing AICS patients as well as the professionals who take care of them with a complete clinical assessment which enlightens the patient on his psychopathological functioning and / or his disorders, and which guides the care through the axes of intervention to be implemented in response to the criminological and non-criminological needs of the patient. This should allow the latter a better awareness (awareness) of his difficulties in the relationship with the other, facilitate his adherence to care, obtain a better commitment on his part in the process of change and consequently, bring him change their lifestyle and gradually adopt proactive attitudes and behavior that ultimately reduce the risk of recidivism of sexual and general violence. However, recourse to MIDSA as a "change operator" in a patient's trajectory is only possible if it is accompanied by a resumption of his clinical assessment by a professional who supports the change process by strengthening his motivation to change their criminal behavior.

Conditions
Offense, Sex
Being tested
MIDSA, Usual methods of evaluation
Keywords
sexual offenders;MIDSA
Medical subject headings
Coitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MIDSABehavioural

    Multidimensional Inventory of Development, Sex, and Aggression

  • Usual methods of evaluationBehavioural

    Usual methods of evaluation of each of the participating centers (CMP / CRIAVS / private practitioners, etc.).

Study groups in NCT05013996
Study groupRoleWhat they receive
InterventionExperimentalPatients randomized to the experimental (MIDSA groupe) will be treated according to the usual methods of each of the centers (CMP / CRIAVS / private practitioners, etc.) completed with the Multidimensional Inventory of Development, Sex, and Aggression-MIDSA groupe Multidimensional Inventory of Development, Sex, and Aggression-inventory tool.
Receives: Behavioral: MIDSA
ControlActive comparatorPatients randomized to the control group will be treated according to the usual methods of each of the participating centers (CMP / CRIAVS / private practitioners, etc.).
Receives: Behavioral: Usual methods of evaluation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in behavior

    Change in behavior (awareness of its difficulties, commitment to care, motivation to abandon the previous lifestyle, etc.) and with reference to the transtheoretical model of stage change, it will be measured using the University of Rhode Island Change Assessment (URICA) by the rate of patients with a stage of change at Month 6 higher than that observed at D0

    Measured: up to 6 months

Secondary outcomes (6)
  1. Assessment of the risk for sexual violence (RSVP)

    The risk assessment for sexual violence will be performed by the Risk for Sexual Violence Protocol (RSVP; Hart et al., 2003);cut-off score: 0-44 (lowrisk); score: 45-132 moderate to high risk

    Measured: up to 1 year

  2. Assessment of the risk of violence (in general) and the risk factors of the sexual offenders

    The assessment of the risk of violence (in general) and the risk factors of the sexual offenders will be carried out from the Level of Service Inventory / Case Management Inventory (LS / CMI; Andrews , Bonta, \& Wormith, 2000; Guay, 2008);

    Measured: up to 1 year

  3. Assessment of the multidimensional self-esteem assessment (SEI)

    The multidimensional self-esteem assessment will be carried out by the Self-Esteem Inventory (SEI; Coopersmith, 1981) with 4 dimensions: general, social, family and professional self-esteem;

    Measured: up to 1 year

  4. Quality of life assessment

    The quality of life assessment will be carried out by the World Health Organization Quality Of Life (WHOQOL-brief); Leplege, Reveillere, Ecosse, Caria, \& Riviere, 2000; The WHOQOL Group, 1998) around four dimensions: physical health, psychological health, social relations and the environment.

    Measured: up to 1 year

  5. Assessment of social desirability will be carried out by the MCSDS

    The assessment of social desirability will be carried out by the Marlow-Crowne Social Desirability Scale (MCSDS) through its brief version of 20 items

    Measured: up to 1 year

  6. Assessment of Risk factors and protective factors against violence

    Risk factors and protective factors against violence are assessed through a semi-structured interview (for assessment of Risk for Sexual Violence Protocol (RSVP), Level of Service Inventory/Case Management Inventory (LS / CMI) and Structured Assessment of Protective Factors (SAPROF))

    Measured: up to 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Aug 2021
  2. Study start20 Jan 2022
  3. Primary completion14 Jan 2025
  4. Study completion14 Jan 2025

Why it stopped: 10 patients out of 152 expected over 3 years of inclusion. There are many reasons for this failure (staff recruitment, duration of MIDSA..).

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
open label multicenter randomized controlled trial
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05013996
Sponsor's protocol ID
EV-AICS (DR190059)
Other IDs
2020-A02628-31, DR190059
Acronym
EV-AICS
Status last verified
Nov 2025
First submitted
3 Jun 2021
Last updated
24 Nov 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing MIDSA and Usual methods of evaluation in people with Offense, Sex, run by University Hospital, Tours at 5 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 24 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: 10 patients out of 152 expected over 3 years of inclusion. There are many reasons for this failure (staff recruitment, duration of MIDSA..).). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in behavior (time frame: up to 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in